ERIC F GLASSY
Allopathic & Osteopathic Physicians|Pathology|Anatomic Pathology & Clinical Pathology RANCHO DOMINGUEZ, CA NPI 1962455337
Browse related groups: Allopathic & Osteopathic Physicians|Pathology|Anatomic Pathology & Clinical Pathology CA Roche Diagnostics Corporation All categories
General Payments — all program years on this page
$99,068.65
- Category: General Payments
- Program years: PY2018–2024
- Record count: 75
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $9,952.91 across 7 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $9,532.50 | 2 |
| Food and Beverage | $400.41 | 4 |
| Travel and Lodging | $20.00 | 1 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Roche Diagnostics Corporation | $7,599.20 | 5 |
| LEICA MICROSYSTEMS INC. | $2,292.50 | 1 |
| Acerta Pharma LLC | $61.21 | 1 |
By program year
Records — PY2024 (7)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1089610742 | Roche Diagnostics Corporation | $20.00 | 09/10/2024 | Travel and Lodging | Undisputed | 01/23/2026 | View at CMS |
| 1089610744 | Roche Diagnostics Corporation | $103.58 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1089610746 | Roche Diagnostics Corporation | $111.39 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1089610748 | Roche Diagnostics Corporation | $124.23 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1089610750 | Roche Diagnostics Corporation | $7,240.00 | 11/05/2024 | Consulting Fee | Undisputed | 01/23/2026 | View at CMS |
| 1105441138 | AstraZeneca Pharmaceuticals LP | $61.21 | 10/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1142971508 | LEICA MICROSYSTEMS INC. | $2,292.50 | 03/02/2024 | Consulting Fee | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.